Top Stories
There has been a consistent increase in KSM (Key starting material) prices for the last few months across globe.
Standfirst:There is growing awareness of the valuable role that diagnostics can play, both in the early identification and treatment of dangerous or infectious diseases as well as genetic disorders.
Compliance is a serious issue for India’s pharmaceutical manufacturers, distributors, and retailers; due to the complicated nature of the pharmaceutical supply chain. Serialization requires pharmaceutical manufacturers to invest in new technology and adapt their current processes and systems.
What is a biosimilar?
Whereas generic drugs are identical copycats of small-molecule chemical products, biosimilars are only similar to biologic products; innately more complex than chemical products, biologics are large-molecule, organic drugs, subject to natural variability and vulnerability due to climate changes during the manufacturing process, and as such, it is impossible to produce an exact replica of a biologic—hence the adoption of the nomenclature, “biosimilar.”
Every day, the United States loses 116 lives to the opioid epidemic.(1) Pharmacists are asking what can be done to combat the opioid epidemic and treat pain effectively.
CRM, CLM, KAM, Big Data, customer focus, patient centricity… for the last 20 years,buzzwords and concepts have been raining down on the Pharmaceutical Industry, generating a flurry of projects, proof of concepts, pilots and even some successful implementations.
Upcoming Events
03
Oct, 2018
09
Oct, 2018
10
Apr, 2019
25
Nov, 2019
Interview & Whitepapers
News & Press Releases
Thermo Fisher Scientific Inc., the world leader in serving science, announced its intent to open multiple Global Customer Solution Centers.
Pioneering partners Cmed and Innovative Physics have combined forces to showcase The Real Time Medical Imaging Users Tool Kit®, which uses artificial intelligence to support secure, rapid diagnostics in clinical trials, at DPharm 2018.
Specialty Chemicals Company LANXESS is to be represented in two Dow Jones Sustainability Indices again this year. Starting from September 24, 2018, LANXESS will be listed in the Dow Jones Sustainability Index (DJSI) World for the eighth time in a row.
CPhI Worldwide the world’s largest pharma event – taking place in Madrid (9-11, October 2018) and organized by UBM (part of Informa plc) – has released the second part of its annual report, which evaluates the effects of regulatory divergence, trade agreements and IP rights over the next 5-years.
Neurimmune announced the achievement of a key preclinical milestone in the ongoing collaboration with Ono Pharmaceutical Co., Ltd. In November 2017, the parties entered into a collaboration focused on the development of human-derived antibodies against a novel therapeutic target for neurodegenerative diseases.
Smart Home and Horticultural Lighting Under Spotlight
Current Events
- 09 October 2018 - 11 October 2018
- FEMA, Feria de Madrid, Madrid
- Spain
- 10 April 2019 - 12 April 2019
- Bologna
- Italy
- 25 November 2019 - 28 November 2019
- Shanghai New International Expo Centre (SNIEC)
- China
Oxford Genetics, a leader in innovative synthetic biology-based technologies for biologics discovery, development and delivery, and ERS Genomics have extended their pre-existing non-exclusive, license agreement for the use of CRISPR gene editing technology.
ADC Biotechnology (ADC Bio) predicts that the next crucial phase of innovation to optimise and streamline production processes of ADCs will be designed at the clinical development stage by specialist, ADC focused service providers.
Biogen and Neurimmune announced that Biogen has exercised its option to further reduce the previously negotiated royalty rates payable on potential future sales of aducanumab, Biogen’s Phase 3 investigational treatment for early Alzheimer’s disease.
GamaMabs Pharma, a biotechnology company developing optimized therapeutic antibodies targeting the Anti-Müllerian Hormone Receptor II (AMHRII) for the treatment of cancer, announces that it has dosed the first patient in its Phase 2 clinical trial - of GM102 single agent and in combination with Trifluridine/Tipiracil (Lonsurf) - in patients with advanced or metastatic colorectal cancer (CRC).
Thrombolytic Science, LLC (TSI) today announced initiation of a Phase 2 clinical trial to confirm the efficacy and safety of its sequential dual-treatment regimen of low-dose tissue plasminogen activator (tPA) and HisproUK (TSI’s mutant prourokinase [proUK]) in patients who have experienced ischemic stroke.
CRF Health, the leading provider of patient-centered eSource technology solutions for the life sciences industry, announced that its TrialMax® Slate solution has been selected by a US biotech company for a global Phase III prostate cancer study.
Medical Technology company IME Medical Electrospinning, developer, producer and scientific partner in the field of biomedical electrospinning processes and equipment, announced that its high-end laboratory and a brand new set of cleanrooms have become operational.
STA Pharmaceutical Co., Ltd., (WuXi STA) – a subsidiary of WuXi AppTec – and Antengene Corporation, a biopharmaceutical company, recently announced a strategic partnership for the CMC development and manufacturing of innovative oncology drugs.
Medical technology company IME Technologies, developer, producer and scientific partner in the field of biomedical electro spinning processes and equipment, has moved its operations from Geldrop to a significantly larger facility in Waalre with effect from 26 March.
Hermetic packages protect pharmaceutical products from external influences like humidity, oxygen and light.
Bosch Packaging Technology showcases laboratory competence in R&D and Industry 4.0
Pharmaceutical products without proper labelling impact patient safety, and the lack of temperature monitoring during storage and transportimpacts the efficiency of those products.
-
Healthplex & Nutraceutical Products China, a one-stop commerce & trade platform for the whole industry chain integrated with health products, health ingredients, pharmaceutical ingredients was successfully held with nearly 3,800 domestic and foreign well-known exhibitors participated in the exhibition.
Healthplex and Nutraceutical Products China, a one-stop commerce and trade platform for the whole industry chain integrated with health products, health ingredients and pharmaceutical ingredients was successfully held with CPhI China and Hi China from 20 to 22 June 2018 in SNIEC, Shanghai for the ninth time.
With a total exhibition area of 220,000 square meters, nearly 3,800 domestic and foreign well-known pharmaceutical ingredients, health ingredients, and health finished products exhibitors participated in the exhibition. -
-
-
